Sangamo Therapeutics (NASDAQ: SGMO) gains ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Sangamo (SGMO) Partner Pfizer (PFE) is Encouraged by Emerging Data from SB-525 - Truist SecuritiesAugust 20, 2020 10:57 AM Sangamo BioSciences (SGMO) Potential Fair Value Goes to $32/Share on BMRN CRL - Truist SecuritiesAugust 19, 2020 1:02 PM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $120 at Baird; Sees at Least a 2-Year Valrox Delay Following CRLAugust 19, 2020 11:30 AM